Class information for:
Level 1: PLERIXAFOR//LARGE VOLUME LEUKAPHERESIS//STEM CELL MOBILIZATION

Basic class information

ID Publications Average number
of references
Avg. shr. active
ref. in WoS
1302 2629 30.7 80%



Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)



ID, lev.
above
Publications Label for level above
283 18382 EXPERIMENTAL HEMATOLOGY//G CSF//PLERIXAFOR

Terms with highest relevance score



Rank Term Type of term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 PLERIXAFOR Author keyword 140 72% 4% 111
2 LARGE VOLUME LEUKAPHERESIS Author keyword 61 95% 1% 20
3 STEM CELL MOBILIZATION Author keyword 49 41% 4% 93
4 PERIPHERAL BLOOD STEM CELLS Author keyword 49 37% 4% 104
5 POOR MOBILIZERS Author keyword 44 100% 1% 16
6 LEUKAPHERESIS Author keyword 39 39% 3% 78
7 MOBILIZATION Author keyword 31 15% 7% 191
8 CD34 CELLS Author keyword 30 22% 5% 121
9 PBPC MOBILIZATION Author keyword 27 78% 1% 18
10 CD34 Author keyword 23 11% 8% 203

Web of Science journal categories

Author Key Words



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
LCSH search Wikipedia search
1 PLERIXAFOR 140 72% 4% 111 Search PLERIXAFOR Search PLERIXAFOR
2 LARGE VOLUME LEUKAPHERESIS 61 95% 1% 20 Search LARGE+VOLUME+LEUKAPHERESIS Search LARGE+VOLUME+LEUKAPHERESIS
3 STEM CELL MOBILIZATION 49 41% 4% 93 Search STEM+CELL+MOBILIZATION Search STEM+CELL+MOBILIZATION
4 PERIPHERAL BLOOD STEM CELLS 49 37% 4% 104 Search PERIPHERAL+BLOOD+STEM+CELLS Search PERIPHERAL+BLOOD+STEM+CELLS
5 POOR MOBILIZERS 44 100% 1% 16 Search POOR+MOBILIZERS Search POOR+MOBILIZERS
6 LEUKAPHERESIS 39 39% 3% 78 Search LEUKAPHERESIS Search LEUKAPHERESIS
7 MOBILIZATION 31 15% 7% 191 Search MOBILIZATION Search MOBILIZATION
8 CD34 CELLS 30 22% 5% 121 Search CD34+CELLS Search CD34+CELLS
9 PBPC MOBILIZATION 27 78% 1% 18 Search PBPC+MOBILIZATION Search PBPC+MOBILIZATION
10 CD34 23 11% 8% 203 Search CD34 Search CD34

Key Words Plus



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 PLUS G CSF 139 74% 4% 104
2 LARGE VOLUME LEUKAPHERESIS 91 70% 3% 75
3 BLOOD PROGENITOR CELLS 82 32% 8% 215
4 AUTOLOGOUS TRANSPLANTATION 64 22% 10% 260
5 G CSF 61 15% 14% 360
6 HIGH DOSE CHEMOTHERAPY 54 11% 17% 454
7 BLOOD STEM CELLS 52 34% 5% 126
8 PLATELET RECOVERY 51 37% 4% 109
9 COBE SPECTRA 50 88% 1% 23
10 NON LYMPHOBLASTIC LEUKEMIA 47 62% 2% 48

Journals



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 JOURNAL OF HEMATOTHERAPY 18 35% 2% 42
2 JOURNAL OF CLINICAL APHERESIS 12 13% 3% 90
3 INTERNATIONAL JOURNAL OF CELL CLONING 6 12% 2% 50
4 JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH 4 11% 2% 40

Reviews



Title Publ. year Cit. Active references % act. ref.
to same field
Optimizing Autologous Stem Cell Mobilization Strategies to Improve Patient Outcomes: Consensus Guidelines and Recommendations 2014 15 160 68%
The biology and clinical uses of blood stem cells 1997 521 200 51%
CD34: Structure, biology, and clinical utility 1996 659 111 34%
Preemptive use of plerixafor in difficult-to-mobilize patients: an emerging concept 2012 21 38 92%
Therapeutic relevance of CD34(+) cell dose in blood cell transplantation for cancer therapy 2000 191 103 50%
Advances in stem cell mobilization 2014 9 141 38%
Improving stem cell mobilization strategies: future directions 2009 98 130 56%
Current status of stem cell mobilization 2010 47 137 58%
The evolving role of plerixafor in hematopoietic progenitor cell mobilization 2013 6 77 77%
Structural and functional features of the CD34 antigen: an update 2001 79 75 53%

Address terms



Rank Address term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ.
in class
1 UTAH BLOOD MARROW TRANSPLANT PROGRAM 6 80% 0.2% 4
2 HPC TRANSPLANT PROGRAMME 6 100% 0.2% 4
3 HEMATOL ONCOLHEMATOPOIET STEM CELL TRANSPLAN 4 75% 0.1% 3
4 HEMATOL STEM CELL TRANSPLANTAT CLIN 4 75% 0.1% 3
5 ANALYT CLIN BIOCHEM 3 100% 0.1% 3
6 UNITE BIOCLIN PRELEVEMENT TRAITEMENT CELLULES S 3 100% 0.1% 3
7 CLIN HE IS UNIT 3 50% 0.2% 4
8 SERV BIOTHER IES 3 50% 0.2% 4
9 MED ONCOL BLOOD DIS 3 60% 0.1% 3
10 IMMUNOHEMATOL SECT 3 32% 0.3% 7

Related classes at same level (level 1)



Rank Relatedness score Related classes
1 0.0000185265 HAPLOIDENTICAL//NORMAL DONORS//T CELL DEPLETION
2 0.0000136065 TRANSPLANT RATES//EBMT ACT SURVEY OFF//OPERAT COMPUTAT FINANCE
3 0.0000117941 BONE MARROW PURGING//MARROW PURGING//MAFOSFAMIDE
4 0.0000111687 EX VIVO EXPANSION//CYTOKINE MEDIATED EXPANSION//AFT024
5 0.0000076947 G CSF//GM CSF//GRANULOCYTE COLONY STIMULATING FACTOR
6 0.0000076936 CORD BLOOD TRANSPLANTATION//UMBILICAL CORD BLOOD//CORD BLOOD
7 0.0000065369 PEGFILGRASTIM//FEBRILE NEUTROPENIA//FILGRASTIM
8 0.0000058810 MULTIPLE MYELOMA//LENALIDOMIDE//BORTEZOMIB
9 0.0000052992 FOLLICULAR LYMPHOMA//NON HODGKINS LYMPHOMA//AGGRESSIVE NON HODGKINS LYMPHOMA
10 0.0000049808 LYMPHOCYTE RECOVERY//IMMUNE RECONSTITUTION//BMT RECIPIENTS